CP1.AX - Cannpal Animal Therapeutics Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
31/03/2017
Operating expenses
Research development
1,793
1,558
661.317
-
Selling general and administrative
670.642
797.491
1,007
-
Total operating expenses
2,560
2,408
1,900
-
Operating income or loss
-2,560
-2,408
-1,900
-
Total other income/expenses net
654.421
297.3
129.113
-
Income before tax
-1,812
-2,007
-1,694
-
Income tax expense
0
0
0
-
Income from continuing operations
-1,812
-2,007
-1,694
-
Net income
-1,812
-2,007
-1,694
-
Net income available to common shareholders
-1,812
-2,007
-1,694
-
Basic EPS
-
-0.02
-0.02
-
Diluted EPS
-
-0.02
-0.02
-
Basic average shares
-
93,125
83,973
37,550
Diluted average shares
-
93,125
83,973
37,550
EBITDA
-
-2,408
-1,900
-